Cumayas, Reven .
HRN: 23-02-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2024
CLOXACILLIN 500MG (CAP)
04/25/2024
05/02/2024
PO
500mg
TID
S/P Percutaneous Pinning, Left Radius
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes